[Current Biology] Scientists investigated how cells shape and pack in 3D within a dense tissue with multiple cell types and spatiotemporally varying boundary constraints. They focused on the developing skeletal muscle in zebrafish.
[Cell Reports] Researchers demonstrated that exercise-induced exerkine clusterin mediates the pro-regenerative effects of running plasma on cardiac repair and cardiomyocyte proliferation following myocardial infarction.
[Cell Reports] Using patient-specific iPSC-derived cardiomyocytes and engineered heart tissues, the authors identified reduced survival motor neuron expression, mitochondrial respiratory defects, and impaired contractility in spinal muscular atrophy.
[Communications Biology] The authors evaluated the cardiogenic potential of satellite cells and mesenchymal progenitor cells from the masticatory muscle by reproducing, optimizing and diversifying previously described protocols.
[npj Biomedical Innovations] The authors address the role of delivery in overcoming challenges in cardiac adeno-associated viral therapies. Emphasis is placed on biomaterial-based delivery approaches to improve therapeutic outcomes.
[Nature Genetics] Investigators used genetic multiplexing to generate population-scale single-nucleus chromatin accessibility and transcriptome maps across 287 frozen human skeletal muscle biopsies. The results of this study illuminate the genetic regulatory architecture of human skeletal muscle.
[FibroBiologics, Inc.] FibroBiologics, Inc. announced that the European Patent Office has granted European Patent No. EP 4454709, titled "Fibroblast Delivery of Tumor Inhibitory Agents. The patent covers methods of preparing fibroblasts as anti-cancer delivery compositions by modifying the cells to improve their ability to home to cancer cells.
[Applied Biologics, LLC.] Applied Biologics, LLC. announced the completion of enrollment into the sentinel safety cohort of its Phase III randomized controlled clinical trial evaluating BIOxHEAL™ in patients with chronic, nonhealing diabetic foot ulcers.
[StimLabs ] StimLabs announced the commercial launch of DermaForm, an FDA 510(k)-cleared porcine-derived particulate collagen scaffold that manages a range of acute and chronic wounds.